Chlorambucil

This publication has 22 references indexed in Scilit:

• CLINICAL EVALUATION OF CB 1348 IN MALIGNANT LYMPHOMA AND RELATED DISEASES
  Annals of the New York Academy of Sciences, 1958
• CLINICAL EVALUATION OF CB 1348 IN LEUKEMIAS AND LYMPHOMAS
  Annals of the New York Academy of Sciences, 1958
• SUMMARY OF RESULTS OBTAINED WITH CB 1348
  Annals of the New York Academy of Sciences, 1958
• CHLORAMBUCIL AND TRIETHYLENE THIOPHOSPHORAMIDE IN THE TREATMENT OF NEOPLASTIC DISEASE
  Annals of the New York Academy of Sciences, 1958
• p-(D1-2-CHLOROETHYL) AMINOPHENYLBUTYRIC ACID (CB 1348) IN THE TREATMENT OF CANCER
  Annals of the New York Academy of Sciences, 1958
• REMISSIONS INDUCED BY CHLORAMBUCIL IN CHRONIC GRANULOCYTIC LEUKEMIA
  JAMA, 1958
• Clinical experience with CB 1348 (NN-DI(2-chloroethyl,-p-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia
  Acta Radiologica, 1957
• Evaluation of CB 1348 in Hodgkin's Disease and Allied Disorders
  Archives of internal medicine (1960), 1956
• Early experience withp-(N,N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia
  Cancer, 1956
• Clinical Trials of p-(Di-2-chloroethylamine)-phenylbutyric Acid (CB 1348) in Malignant Lymphoma
  BMJ, 1955